Study Stopped
Covid situation / recruitment difficulties
Longitudinal Follow-up of High Viscosity Glassionomer IonoStar Plus Versus a Composite Bulk X-tra-Fil Combined With Futurabond U (Splith Mouth Study): Reunion Island, Circus of Mafate
CVB
1 other identifier
interventional
65
1 country
1
Brief Summary
The main objective is the longitudinal follow-up and comparison of the maintenance of the dental filling materials up to 24 months using the HVGIC IonoStar Plus versus Bulk X-Tra -Fil composite (Futurabond U adhesive system). 150 patients will be recruited in the Mafate dental health center. Patients with minimum 2 carious lesions (or multiple of 2, maximum 6) class I or II moderate not including the cusps, and touching the outside part of the middle of dentin. Assignment period will be 4 years: Inclusion period 18 months with 2 years following (6-month, 1 year and 2 years checking) and 3 months for statistical analysis and publications process Estimation of the parameters associated with a failure of the restoration at 24 months will follow the FDI scores. The Secondary objectives are to evaluate the caries risk of isolated population thanks to Cambra application and estimate the concordance of the judgment of maintaining the restoration between the expert in-situ and experts based on the images remotely.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2018
CompletedFirst Posted
Study publicly available on registry
June 26, 2018
CompletedStudy Start
First participant enrolled
September 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2023
CompletedAugust 12, 2024
August 1, 2024
4.7 years
May 14, 2018
August 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the International Dental Federation Score
Score are numbered from 1 to 5 in ascending order of severity for aesthetic criteria (5 items), functional criteria (9 items) and biological criteria (6 items). The score will be used by the practionner making the restoration and by the remote expert to check the results and validate tele-dentistry evaluation.
Change from Baseline Score FDI at 2 years
Secondary Outcomes (2)
Validation of the caries risk assememt.
Change from Baseline caries risk assement at 2 years
The carious presence according to the ICDAS / ICCMS criteria using the Soprolife® camera
At each follow-up visit (T0, T6 months, T1year and T2years)
Study Arms (2)
Bulk fil composite
ACTIVE COMPARATORHigh viscosity glass ionomer
ACTIVE COMPARATORInterventions
Treatment by Bulk fil composite after randomization of the tooth
Eligibility Criteria
You may qualify if:
- Patient with 2 carious lesions (or multiple of 2) class I or II moderate not including the cusps, and touching the outside part of the middle of dentin
- Asymptomatic tooth or with a reversible pulp syndrome tooth
- Patient consultant in investigative testing center
- Patient of 18 to 70 years old
- Patient able to support care
- Patient able to understand care (no language barrier)
- Collect the informed consent signed after a period of reflection
- Be affiliated to a French social security scheme or recipient of such a regime
- Tooth with criteria for pulp vitality tests of pulp sensibility
You may not qualify if:
- Patient under guardianship
- Pregnant or breastfeeding
- Patient at risk for infectious endocarditis
- Patient with severe periodontal disease (Pocket depth ≥ 5mm and/or mobility IV)
- Patient with an allergy to one of the materials used in the study
- Patient with an allergy to local anesthesia
- Patient with risks of infectious endocarditis
- Non-cooperative patient
- Participate in another ongoing biomedical research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Montpellier
Montpellier, 34090, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2018
First Posted
June 26, 2018
Study Start
September 21, 2018
Primary Completion
May 20, 2023
Study Completion
May 20, 2023
Last Updated
August 12, 2024
Record last verified: 2024-08